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Bone tissue engineering approaches are encouraging for the improvement of
conventional bone grafting technique drawbacks. Thanks to their self-renewal and
multi-lineage differentiation ability, stem cells are one of the major actors in
tissue engineering approaches, and among these adult mesenchymal stem cells
(MSCs) hold a great promise for regenerative medicine strategies. Bone marrow
MSCs (BM-MSCs) are the first- identified and well-recognized stem cell population
used in bone tissue engineering. Nevertheless, several factors hamper BM-MSC
clinical application and subsequently, new stem cell sources have been investigated
for these purposes. The fruitful selection and combination of tissue engineered
scaffold, progenitor cells, and physiologic signaling molecules allowed the surgeon
to reconstruct the missing natural tissue. On the basis of these considerations,
we analyzed the capability of two different scaffolds, planned for osteochondral
tissue regeneration, to modulate differentiation of adult stem cells of dissimilar local
sources (i.e., periodontal ligament, maxillary periosteum) as well as adipose-derived
stem cells (ASCs), in view of possible craniofacial tissue engineering strategies.
We demonstrated that cells are differently committed toward the osteoblastic
phenotype and therefore, taking into account their specific features, they could be
intriguing cell sources in different stem cell-based bone/periodontal tissue regeneration
approaches.
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Introduction
Reconstruction of large bone and/or complex craniofacial defects is a clinical challenge in
situations of injury, congenital defects or disease. The use of cell-based therapies represents
one of the most advanced methods to enhance the regenerative response for bone wound
healing. As suggested by Giannoudis et al. (2007), in addition to 3D dimensional structures,
mechanical, and/or physical signals, cell type as well as environmental bioactive factors
are critical to direct tissue repair and regeneration. Both somatic and stem cells have
been adopted in the treatment of complex osseous defects and, among these, mesenchymal
stem cells (MSCs) held the greatest promise for regenerative therapies in the skeletal
system. MSCs are multipotent and self-renewing cells owning endogenous functions for
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tissue renewal and repair within their individual local tissues
(van der Kooy and Weiss, 2000). The term MSCs was originally
generated considering a theoretical common progenitor of
a wide range of “mesenchymal” tissues (Caplan, 1991) and
these cells are commonly identified because of their surface
phenotype and in vitro ability to differentiate into specific
lineages (Dominici et al., 2006). Even though it has been
widely accepted that MSCs reside ubiquitously throughout a
variety of post-natal tissues and organs (Crisan et al., 2008),
this concept undergoes to strong criticism for the missing
of an essential in vivo experimental support (Bianco et al.,
2013). Moreover, recent literature suggests that not all MSCs
are certainly created equal in their differential and proliferative
capacities, or in their capability to respond to external influences
(i.e., microenvironment). Cells harvested from different sources
may in fact show phenotypic heterogeneity and dissimilar
in vivo results after transplantation (Rebelatto et al., 2008). For
researchers investigating stem cell-based tissue engineering, it
is essential to select the most appropriate type of MSCs source
naturally suited to obtain a more efficient treatment for the
regeneration of injured skeletal tissues of different anatomical
districts.
To this aim, we tested the cross-talk between 3D porous
scaffolds and MSCs derived from different adult human tissues.
The choice of the different MSCs population harvesting sites (i.e.,
periosteum, periodontal ligament and adipose tissue) was based
on their possible regenerative medicine applications in complex
craniofacial lesions.
Periosteum derived precursor cells (PDPCs) reside in the
inner “cambium layer” of periosteum which is a connective
structure comprised of 2 layers that covers the external
surface of bone (Roberts et al., 2015). Specifically, besides
osteoblasts and bone lining cells, the inner layer has adult
mesenchymal skeletal progenitor cells, smaller and more
isodiametric fibroblasts, and sympathetic nerves that make
periosteum a structure with regenerative capacity (Ferretti
and Mattioli-Belmonte, 2014a; Lin et al., 2014). Periodontal
ligament stem cells (PDL-SCs) that reside at the perivascular
regions possess characteristics of MSCs and are a promising
tool for periodontal regeneration (Zhu and Liang, 2015). At
last, Adipose-derived Stem Cells (ASCs) were found to be
more suitable in clinical application in comparison with those
derived by bone marrow for higher stem cells harvest from
lipoaspirates, faster cell proliferation and less discomfort and
morbidities during collecting procedure. However, conflicting
results on their osteogenic capacity is now still debated
(Liao and Chien, 2014).
In this study, PDPCs, PDL-SCs, and ASCs were seeded
on two kinds of gelatin/genipin scaffolds for 14 and 21 days
and cultured in appropriate differentiating media in order
to mimic a chondrogenic or osteogenic microenvironment.
Cell proliferation assay, light microscopy, transmission
(TEM) and scanning (SEM) electron microscopies and
qRT-PCR were carried out to evaluate cell viability,
morphological and functional changes induced by cell/scaffold
interaction.
Materials and Methods
Cell Culture
Periosteal Derived Progenitor Cells (PDPCs)
PDPCs were obtained from maxillary periosteal tissue of four
subjects undergoing routine oral surgery (mean age 34 years),
after the obtainment of their informed consent. As previously
described (Ferretti et al., 2012, 2014b), tissue was washed in
Dulbecco’s Phosphate-Buffered Saline (D-PBS) lacking in Ca2+
and Mg2+, minced into small pieces (4–9mm2) and then
placed in a 100mm Petri dish in Dulbecco’s Modified Eagle
Medium: Nutrient Mixture F-12 (DMEM/F-12, Sigma-Aldrich,
Milan, Italy) supplemented with 10% Fetal Bovine Serum (FBS)
and 1% penicillin-streptomycin (100U/ml), all from GIBCO R©
(Life Technologies Corporation, USA). DMEM-F12 provides
optimal and appropriate culture conditions for MSCs isolation
and ex vivo expansion, preserving the correct morphology,
population doubling time and immunophenotype (Pal et al.,
2009). Periosteum explants were positioned with their cambium
side placed against the dishes to allow cell adhesion. Petri dishes
were incubated at 37◦C in a humidified, CO2-controlled (5%)
incubator. Medium was changed twice a week. As soon as cells
migrating from the explants reached 50% of confluence, they
were collected by treatment with 0.25% trypsin/1mM EDTA
(Sigma-Aldrich, Milan, Italy) and subcultured at 1:3 dilutions
under the same culture condition. Cells were used at the 3rd
passage to assess their MSC phenotype and their ability to
differentiate into mesenchymal lineages.
Periodontal Ligament Stem Cells (PDL-SCs)
Periodontal ligaments tissues were obtained from extracted
human molars, of 10 healthy volunteers aged 16–30 years.
Written informed consent was obtained from all donors. As
previously described (Orciani et al., 2012), periodontal ligaments
tissues were cut in small pieces and cultured in Petri dishes
in Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-
12 (DMEM/F-12) (Gibco, Life Technologies, Milan, Italy)
containing 10% FBS, penicillin (100U/mL) and streptomycin
(100µg/mL) (Gibco, Life Technologies, Milan, Italy). Cells
were grown until 50% confluence was reached, then they
were harvested by treatment with 0.25% trypsin/1mM EDTA
(Gibco, Life Technologies, Milan, Italy) and re-plated at
1:2 dilutions under the same culture condition. Cells were
used at the 3rd passage for phenotypic characterization and
differentiation.
Adipose Derived Stem Cells (ASCs)
StemPro R© Human ASCs were purchased from Life Technologies
Corporation (Monza, Italy). Cells were grown in MesenPRO
RS™ Basal Medium (Life Technologies, Monza, Italy)
supplemented with MesenPRO RS™ Growth Supplement
(Life Technologies, Milan, Italy) according to the manufacture’s
suggestions. ASCs were expanded to 4–5 passages before they
lost the capacity to grow or differentiate into all potential
phenotypes.
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Cell Characterization
According to The International Society for Cellular Therapy for
identification of human MSCs (Dominici et al., 2006), PDPCs,
PDL-SCs, and ASCs were analyzed by flow cytometry and
subjected to differentiation into mesenchymal lineages.
For immunophenotyping, 2.5×105 cells were washed with D-
PBS and then stained for 45min with the following antibodies:
fluorescein isothiocyanate-(FITC)-labeled mouse anti-human
CD90 (Stem Cell Technologies—Milan, Italy), CD105, CD14,
CD19 (Diaclone, France), and R-phycoerythrin-(PE)-labeled
mouse anti-human CD34, CD45 (Diaclone, France), CD73
(Becton Dickinson) and anti HLA-DR purchased from Diaclone.
Control for FITC or PE coupled antibodies was an isotypicmouse
IgG1.
Flow cytometric analysis was performed on a FACSCalibur
system (Becton Dickinson, CA, USA) using CellQuest software
(Becton Dickinson). To evaluate fibroblastic contamination,
we tested FITC-labeled mouse anti-human CD9 monoclonal
antibody (ImmunoTools GmbH, Germany) (Halfon et al., 2011).
Cell differentiation into osteoblasts, adipocytes and
chondrocytes was evaluated using STEMPRO R© Osteogenesis,
Adipogenesis and Chondrogenesis Kits (Life Technologies
Corporation, USA) respectively. Cells cultured in DMEM/F-12
with 10%FBS were used as negative controls.
For osteoblastic differentiation, cells were plated at a density
of 4.5 × 104 cells with appropriate medium for 10 days,
refreshing the medium every 2 days. In order to assess the
osteoblastic differentiation von Kossa and Alkaline phosphatise
(ALP) stainings were performed. For von Kossa stain, cells
were fixed with 4% Paraformaldehyde (PFA) for 15min at
room temperature (RT) and incubated with 1% silver nitrate
solution under UV light for 20min at RT. Unreacted silver
was removed with 5% sodium thiosulfate for 5min. For
ALP staining, cells were fixed with 4% PFA for 15min RT
and washed in 100mM Tris-HCl pH 9.5, 100mM NaCl and
10mM MgCl2 buffer for 10min RT. Cells were then stained
with fast 5-bromo-4-chloro-3-indolyl phosphate and nitroblue
tetrazolium alkaline phosphate substrate (Sigma-Aldrich, Milan,
Italy) for 10min and rinsed in dH2O. Reaction was observed
with a light microscope (Nikon Eclipse 600, Nikon, Milan,
Italy).
For adipogenic differentiation 9 × 104 cells were seeded and
treated with the appropriate medium for 15 days, changing
the media twice a week. Differentiation was assessed by Oil
Red staining and CD36 immunoreaction. Briefly, cells fixed
in 4% PFA were exposed to Oil Red O solution (0.5% in
100% isopropyl alcohol) for 20min RT, cleared with isopropanol
60% and finally washed in dH2O. For the detection of CD36
positivity, PDPCs were incubated with monoclonal anti-CD36
(ImmunoTools GmbH, Friesoythe, Germany) diluted 1:100. The
reaction was visualized using the streptavidin-biotin-peroxidase
technique (DAKO LSAB+/HRP peroxidase kit; Dako SpA,
Milano, Italy). Cells were incubated with 3,3-diaminobenzidine-
DAB (10mg diaminobenzidine in 15ml 0.05M Tris buffer, pH
7.6 and 12µl hydrogen peroxide 30%) and counterstained with
Mayer’s haematoxylin (Bio-Optica SpA, Milan, Italy). Reaction
was examined with a light microscope (Nikon Eclipse 600).
For chondrogenic differentiation, cells were cultured in pellet
culture system. For the preparation of each pellet, aliquots of
1 × 106 cells in 1ml of appropriate medium were spun down at
1200 rpm for 5min. Pellets were cultured for 20 days changing
the medium twice a week. Pellets were then fixed in 4% PFA,
paraffin embedded and sectioned. Sections were exposed to a
solutions of Alcian Blue pH 1 (Bio-Optica) for 20min RT or
Safranin-O (0.1 g in EtOH 100%, working dilution 1: 2 dH2O) for
5min RT and observed with a light microscope (Nikon Eclipse
600).
Scaffold Preparation
3D Gelatin (G) scaffolds (GEL) were obtained using type A
gelatin from pig skin cross-linked with genipin as previously
described (Panzavolta et al., 2013). Briefly, following the addition
of genipin, the foam assumed a blue color due to the binding
with primary amino-groups of the gelatin. For the preparation
of scaffolds containing hydroxyapatite (HA), 10 wt% powders
was added to 140ml of a gelatin solution in order to obtain
a suspension (G/HA). The suspension was maintained under
constant mechanical stirring and subsequently cross-linked with
genipin. The samples were then allowed to jellify in an oven,
washed in a glycine aqueous and finally frozen in liquid N2 and
freeze-dried (GEL/HA scaffold).
Before seeding the scaffolds were sterilized in 70% ethyl
alcohol solution (ETOH; Sigma-Aldrich, Milan, Italy) for 2 h,
washed two times in PBS (GIBCO) for 30min and placed
under UV 15min for each side. In order to improve cell
adhesion, scaffolds were then conditioned overnight in suitable
media at 5% CO2, 37◦C. The media were then discarded and
scaffolds considered ready for seeding. Cells were detached using
0.25% trypsin in 1mM ethylene-diamine- tetracetic -acid (EDTA,
Sigma-Aldrich, Milan; Italy) and seeded at a density of 1 × 104
cell/cm3 by applying 50µL of cell suspension on the samples
placed at 37◦C for 30min in a humified chamber, in order
to avoid the slip down of cells. After 1.5ml of STEMPRO R©
Osteogenesis or STEMPRO R© Chondrogenesis medium was
added to cover G/HA or G scaffolds placed in Corning R© ultra-
low attachment multiwell plates, respectively. Cells were cultured
for 7, 14, and 21 days.
MTT (3-dimethylthiazol-2,5-diphenyltetrazolium
Bromide) Viability Assay
Cell viability was assessed in PDPCs, ASCs, and PDL-SCs after 7,
14, and 21 days of culture in basal and differentiating osteogenic
or chondrogenic media. Cell viability was also evaluated in cells
cultured on GEL and GEL/HA scaffolds. Briefly, after removing
the culture media, 200µL of MTT (3-dimethylthiazol-2,5-
diiphenyltetrazolium bromide, 135038 Sigma-Aldrich) solution
(5mg/mL in phenol red-free DMEM) and 1.8mL DMEM were
added to the multi-well plates and incubated at 37◦C for 3 h.
After discarding the supernatants, 2mL of solvent (4%HCl 1N
in isopropanol absolute) were added to dissolve the dark blue
formazan crystals and quantify them spectrophotometrically
measuring the absorbance at 570 nm (Secoman, Anthelie light,
version 3.8, Contardi, Italy). Data were expressed as percentage
over the respective control culture (see Figure 1 legend).
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FIGURE 1 | Histograms depict MTT viability test performed in PDPCs, PDL-SCs, and ASCs cultured in tissue culture plates for 7, 14, and 21 days in
osteogenic (A) or chondrogenic (B) medium. Data are expressed respectively as percentage over PDPCs, PDL-SCs, and ASCs cultured for 7, 14, and 21 days in
undifferentiating medium; (C) PDPCs and PDL-SCs cultured on GEL/HA scaffolds for 7, 14, and 21 days in osteogenic medium. Data are expressed respectively as
percentage over PDPCs and PDL-SCs cultured in osteogenic media in tissue culture plates in osteogenic media. (D) PDPCs and ASCs cultured on GEL scaffolds for
7, 14, and 21 days in chondrogenic medium. Mean values ± SD are reported.
TABLE 1 | Analysed genes description.
Gene Detected transcript Primer forward (5′->3′) Primer reverse (5′->3′) Annealing T (◦C)
RUNX2 NM_004348.3 CTCGTCCGCACCGACAGCC TACCTCTCCGAGGGCTACCACC 60
BMP2 NM_001200.2 CCAGCCGAGCCAACACTGTGC TCTCCGGGTTGTTTTCCCACTCG 60
SPARC NM_003118.3 CCTGAGGCTGTAACTGAGAGAAAG GTGGGAGGGGAAACAAGAAGATAA 65
BGLAP NM_199173 GACTGTGACGAGTTGGCTGA GCCCACAGATTCCTCTTCTG 64
SOX9 NM_000346 GAGGAAGTCGGTGAAGAACG ATCGAAGGTCTCGATGTTGG 65
Type II Collagen NM_001248899 GGCAATAGCAGGTTCACGTACA CGATAACAGTCTTGCCCCACTT 60
GAPDH * NM_002046.3 AGCCACATCGCTCAGACAC GCCCAATACGACCAAATCC 60
GUSB* NM_000181.2 AAACGATTGCAGGGTTTCAC TCTCGTCGGTGACTGTTCA 81
Runx2, runt-related transcription factor 2; Bmp2, bone morphogenetic protein 2; Sparc, Osteonectin; Bglap, osteocalcin; Sox9, SRY (sex determining region Y)-box 9; Gusb, beta
glucuronidase; Gapdh, glyceraldehyde-3-phosphate dehydrogenase. *Reference genes.
Scanning Electron Microscopy (SEM)
Samples from cell culture tests were fixed in 2% glutaraldehyde
(Sigma-Aldrich) in 0.1M cacodylate buffer (pH 7.4, Sigma-
Aldrich), post-fixed in 1% osmium tetroxide (Sigma, Milan,
Italy), dehydrated in increasing ethanol (Sigma-Aldrich)
concentrations (25, 50, 70, 80, and 100%), CPD-dried, mounted
on aluminum stubs, gold-sputtered by the Edwards Sputter
Coater B150S equipment and observed with a Philips XL 20 SEM
(FEI Italia SRL, Milan, Italy) microscope.
Transmission Electron Microscopy (TEM)
Cells cultured on scaffolds were fixed in 2.5% glutaraldehyde
in 0.1M cacodylate buffer for 2 h at 4◦C and post-fixed in 1%
Osmium tetroxide in 0.1M cacodylate buffer for 30min at room
temperature. Samples were dehydrated in graded ethanol and
finally infiltrated and embedded in RL London White (Fluka,
Sigma Aldrich, St. Louis, Missouri, USA). 100 nm ultra-thin
sections were cut using a Diatome (Diatome, Hatfield, PA,
USA) diamond knife on a NOVA LKB Ultratome. Sections were
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FIGURE 2 | SEM micrographs of cells cultured on GEL/HA (A,B) and GEL (C,D) displaying a good colonization of the 3D scaffolds. At 21 days (insets),
spherical structures (arrows) were present in PDPCs cultured on both tested scaffolds. Similar features were evidenced also in PDL-SCs seeded on GEL/HA (inset
Figure 1C).
picked up on nickel grids and stained with alcoholic uranyl
acetate and Reynold’s lead citrate. Ultrastructural examination
was performed using the Philips CM10 TransmissionMicroscope
(FEI Company, Eindhoven, The Netherlands). Images were
recorded by Megaview III digital camera (FEI Company,
Eindhoven, The Netherlands).
Quantitative Real-time Polymerase Chain
Reaction (qRT-PCR)
RNA Extraction, Quantitation and Reverse
Transcription
Total RNA was extracted from cells with TRIzol R© Reagent
(Life Technologies, Milan, Italy) according to the manufacturer’s
protocol. RNA samples were quantified by measuring their
absorbance at 260 nm (bioPhotometer plus, Eppendorf GmbH,
Germany). The Go Script™ RT System (Promega Corporation—
Italy) was used to reverse transcribe 1µg of total RNA in
a 20-µL reaction volume. cDNA neo-synthesized was stored
at−20◦C.
qRT- PCR
Real-time PCR was carried out in white plastic-ware with
a Mastercycler Realplex2 thermocycler (Eppendorf GmbH,
Germany) using the SsoFast™ EvaGreen R© Supermix 1X. All PCR
assays contained 1µL of cDNA (corresponding to 50 ng of total
RNA template) in a 10-µL reaction volume.
The following program was used for amplification: enzyme
activation for 30 s at 95◦C, followed by 40 cycles of denaturation
for 5 s at 95◦C, annealing and extension at 60◦C for 20 s.
Each primer was used at a 200 nM final concentration. Primer
sequences were designed by Primer 3 (v. 0.4.0) software and their
specificity was tested by BLAST Assembled RefSeq Genomes in
order to avoid any appreciable homology to pseudo-genes or
other unexpected targets (Table 1). In each assay, the mRNA of
both reference genes and each gene of interest were measured
simultaneously under equal conditions. Primers showed the same
amplification efficiency. Melting curve analysis furthermore
confirmed the specificity of qRT-PCR reactions.
Quantification of mRNA Expression
Real-time PCR reactions were performed in triplicate and
Ct values of reference genes were used to normalize cellular
mRNA data. In this instance, normalization involved the ratio
of mRNA concentrations of specific genes of interest (as
mentioned above) to that corresponding to Ct medium values
for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and
beta glucuronidase (GUSB) (Ragni et al., 2013). Data were
expressed as gene relative expression (2−1Ct). Furthermore,
in order to highlight the effect of mechanical stimuli on
cells, the 11Ct method for the evaluation of Fold-Change
was employed and cells seeded on plastic were used as an
internal control. The relative amount of each mRNA was
calculated using the comparative threshold (Ct) method with
1Ct = Ct(mRNA) − Ct(GAPDH) and relative quantification
of mRNA expression was calculated with the 2−11Ct method
(Livak and Schmittgen, 2001). The qPCR efficiency in all our
experiments was more than 90%, as the difference between the
actual and theoretical (100%) efficiencies would result in an
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FIGURE 3 | TEM micrographs of (A) PDL-SCs cultured on gelatin/hydroxyapatite (white asterisks) for 14 days (bar: 5 µm); (B) Fibrils (arrows)
resembling the early deposition of extracellular matrix components were detected (bar: 1000nm). The inset shows a detail on collagen type I fibers (bar:
200 nm); (C) PDL-MSCs cultured on gelatin/hydroxyapatite for 21 days (bar: 2000 nm); (D) A high synthesis of extracellular matrix components (arrows) was observed
(bar: 200 nm). The inset shows details on collagen type I fibers detected in the extracellular matrix (bar: 200 nm).
underestimation of the mRNA concentration of all analyzed
samples.
Data in histograms were expressed as fold-regulation that
represents fold-change results in a biologically meaningful way.
In particular, the fold-regulation is equal to the fold-change
(2−11Ct) for fold-change values greater than one, which indicate
an up-regulation. Fold-change values less than one indicate a
down-regulation: in this case the fold-regulation is the negative
inverse of the fold-change (−1/2−11Ct).
Statistical Analysis
Mean and standard deviation of three different experiments are
reported. Data were analyzed by One-Way ANOVA, Student-
Newman-Keuls’s and Student’s T tests. Statistical significance was
tested at p < 0.05
Results
Cell Characterization
PDPCs, PDL-SCs, and ASCs were all plastic-adherent under
standard culture conditions with a fibroblastic, spindle-shape
appearance. All cell populations expressed stromal surface
markers CD73, CD90, and CD105 and were negative for
hematopoietic lineage markers CD45, HLA-DR, CD14, CD19,
and CD34 in agreement with the criteria of the International
Society for Cell Therapy (Dominici et al., 2006). Moreover they
were able to differentiate into all the mesenchymal lineages (data
not shown).
MTT Viability Test
A significant decrease in cell viability was observed in all tested
cells after 14 days of culture in osteogenic or chondrogenic
medium. No changes were detected between 14 and 21 days
of culture (Figures 1A,B). These results well-matched with cell
differentiation.
PDPCs cultured on GEL/HA scaffolds showed a significant
increase of cell viability up to 21 days. A similar behavior
was detected also for PDL-SCs even though at a lower extent
(Figure 1C).
As far as cell seeded on GEL scaffold, PDPCs showed a trend
similar to that observed on GEL/HA, whilst ASCs exhibited an
increase in cell viability after 14 days of culture and then a
decrease at 21 days (Figure 1D).
SEM
Morphological analyses showed the ability of cells to colonize
the porosity of both tested scaffolds (Figure 2). After 21
days (Figure 2 insets) cells covered the entire surface of the
scaffolds, and on PDL-SCs features indicative of induction of
mineralization were detected.
TEM
ASCs cultured for 14 days on gelatin scaffold showed a good
cell adhesion on the surface of the material (Figure 3A).
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FIGURE 4 | TEM micrographs of (A) ASCs observed after 14 days of cultured on gelatin scaffold (white asterisks) (bar: 2000nm); (B) components
(arrows) of the extracellular matrix were detected in ASCs cultured for 14 days on scaffold (bar: 10 µm); (C) ASCs cultured on gelatin scaffold for 21
days. Cells showed a well preserved nucleus and rough endoplasmic reticulum (bar: 1000 nm); (D) Several fibrillary structures (arrow) resembling collagen fibers were
easily observed in the extracellular matrix (bar: 10µm). The inset shows a detail on collagen fibers (bar: 200 nm).
Nucleus and nucleolus were well-evident (Figure 3A) and a
good production of extracellular matrix (ECM) components was
observed (Figure 3B).
After 21 days of culture on gelatin scaffolds, cells showed a
well-developed rough endoplasmic reticulum (RER) suggesting a
high protein synthesis (Figure 3C). ECMmatrix was well-noticed
(Figure 3D) and fibrillar structures connected to collagen fibers
were easily observed (Figure 3D inset).
TEM images regarding PDL-SCs cultured on
gelatin/hydroxyapatite for 14 days demonstrated well-
adhered cells on the scaffold surface (Figure 4A). Nucleus
and cytoplasmic organelles, such as RER, were well-detected
(Figure 4A). Small fibrils resembling the early deposition of
collagen type I were observed (Figure 4B). After 21 days of
scaffold culture PDL-SCs showed a high synthesis of ECM
components with ultrastructurally identified collagen type I
fibrils (Figures 4C,D) inset.
qRT-PCR
Comparison of gene expression results in cells seeded onto
GEL/HA with control culture in plastic are shown in Figure 5A.
Both PDPCs and PDL-SCs showed a reduction in the expression
of runx2 after 14 days of culture on GEL/HA, that was detected
also after 21 days of culture, being significantlymarked in PDPCs.
The same trend was observed in PDPCs for osteonectin (sparc)
mRNA expression. In PDL-SCs we observed a reduction of
mRNA for osteonectin (Fold regulation = −1.5 ± 0.1) after 14
days of culture and its increase (Fold regulation = 2.8 ± 0.6)
after 21 days. As far as osteocalcin (bglap) mRNA expression is
concerned, PDPCs showed its moderate up regulation after 14
days of culture, that became significantly marked after 21 days
(Fold regulation = 6.6 ± 1.2). On the contrary, in PDL-SCs
bglap mRNAexpression was down regulated at both time point
analyzed with a significant decrease after 21 days of culture.
The assessment of changes in gene expression between
21 and 14 days in cells seeded onto GEL/HA scaffolds
compared to those cultured in tissue control plates suggested
a different “commitment” of the diverse MSCs populations
studied (Figure 5B). In PDPCs we observed a significant up-
regulation of bglap on cells seeded on the scaffolds respect
to controls. This up-regulation was concomitant with the
down regulation of sparc mRNA expression and with a
reduced activation of runx2. On the contrary in PDL-SCs
seeded on the GEL/HA scaffolds there were slight changes
in runx2 and sparc mRNA expression in comparison with
controls, whilst we observed a reduction in bglap mRNA
expression.
Overall, these results suggested that PDPCs are more
committed toward an osteoblastic phenotype compared to
PDL-SCs and concomitantly we observed that the scaffold
architecture/composition affect osteoblastic differentiation.
As far as cells seeded on GEL scaffold and induced toward a
chondrogenic differentiation Bmp2 resulted significantly down
regulated in PDPCs, while it remained unchanged in ASCs.
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FIGURE 5 | Histograms depict changes between PDPCs and PDL-SCs mRNA expression of runx2, osteonectin (sparc) and osteocalcin (bglap)
observed after culturing cells for 14 and 21 days on GEL/HA with osteogenic differentiating medium. (A) Fold-changes of PDPCs and PDL-SCs seeded on
scaffold with respect to PDPCs and PDL-SCs control cultures (i.e., PDPCs and PDL-SCs in tissue culture plates with osteogenic differentiating medium); (B) Fold
changes of PDPCs and PDL-SCs seeded on GEL/HA (scaffold) or in tissue control plates (control) at 14 vs. 21 days. Data are expressed as fold-regulation which
represents fold-change results in a biologically expressive manner (see Materials and Method section). Statistical differences with relative controls are denoted with an
asterisk (*p < 0.05).
Sox9 expression was down regulated in both cell cytotypes at
14 days of culture, whilst it appeared unmodified at 21 days of
culture. Results of the comparison of Type II collagen mRNA
expression in cells seeded onto the scaffolds with control culture
in plastic showed a down regulation of this gene at 14 days that
was more marked in ASCs. On the contrary, after 21 days the
production of Type II collagen increased for both tested cytotypes
(Figure 6A).
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FIGURE 6 | Histograms depict changes between PDPCs and ASCs mRNA expression of bmp2, Sox 9 and Collagen Type II observed after culturing
cells for 14 and 21 days on GEL with chondrogenic differentiating medium. (A) Fold-changes of PDPCs and ASCs seeded on scaffolds with respect to control
cultures (i.e., PDPCs and ASCs in tissue culture plates with chondrogenic differentiating medium); (B) Fold changes of PDPCs and ASCs seeded on GEL (scaffold) or
in tissue control plates (control) at 14 vs. 21 days. Data are expressed as fold-regulation which represents fold-change results in a biologically expressive manner (see
Materials and Method section). Statistical differences with relative controls are denoted with an asterisk (*p < 0.05).
The role of a 3D structure in the production of Sox9 and Type
II collagen (i.e., chondrogenic commitment) was confirmed by
changes in gene expression between 21 and 14 days in cells seeded
onto GEL (Figure 6B), in which the increase of mRNA for both
genes was observed only in cells seeded on scaffolds.
Discussion
To restore extensive or complex fracture and/or maxillofacial
defects, autograft has been widely used and it is still considered
as a gold standard (Dimitriou et al., 2011). Autogenous tissue is
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endowed of all the basic elements essential for an effective tissue
regeneration: it provides cells, extracellular matrix and cytokines
(Khan et al., 2005; Pape et al., 2010). Nevertheless, the use of
autograft possesses drawbacks in terms of costs, procedure time,
patient discomfort and possible complications. Moreover, given
the limited availability of autogenous tissues, harvested volume
could be insufficient to fill or cover a defect (Zouhary, 2010).
To overcome these limitations, a variety of exogenous substitutes
has been introduced in clinical practice over the last decades
(De Long et al., 2007). Indeed, the presence of cells, which
orchestrate the release of growth factors and the maintenance of
a stable scaffold is key factor for a positive tissue regeneration
as cells play a pivotal role in the healing process (Taba et al.,
2005). Both somatic and stem cells can be used: the former can
be harvested, cultured and implanted to engineer new tissues.
Restrictions in the application of somatic cells are related to the
lack of self-renewal capability and limited potency, which are
exclusive characteristics of stem cells (Garcia-Godoy andMurray,
2006). Among the latter, MSCs has held a great promise. After
their initial detection in bone marrow, several other sources of
MSCs were identified, including embryonic tissues (umbilical
cord, amnion or placenta), as well as different adult tissues
(skin, dental pulp, periosteum and adipose tissue, among others)
(Salvolini et al., 2010; Ferretti and Mattioli-Belmonte, 2014a;
Lazzarini et al., 2014). Indeed, MSCs of different origin may
vary in their ability to proliferate and/or respond to external
influences (i.e., microenvironment), this behavior could entail
different in vivo results after transplantation. In this respect,
it is crucial to select the most appropriate MSC type for the
healing of different anatomical district injured skeletal tissues.
Moreover, to improve bone healing, researchers must develop
and/or select a scaffold able to maintain, induce and restore
biological functions. Therefore, scaffolds must be evaluated not
only for their capability to preserve MSC survival, but also to
promote their proliferation and differentiation.
In the present study we compared the functional behavior of
MSCs of different origin on two kind of 3D porous scaffolds
intended for bone (GEL/HA) or cartilage (GEL) regeneration. In
order to mimic microenvironment cell cultures were performed
in osteogenic or chondrogenic differentiating medium. MSC
harvesting site (periosteum, periodontal ligament or adipose
tissue) was selected on the basis of experimental evidences of
their possible use in clinical practice.
Periosteum has an inner cambium layer with skeletal
progenitor cells that constantly give rise to osteoblasts for
appositional bone growth and for cortical bone modeling
and remodeling in concert with osteoclasts. The outstanding
periosteum property has produced widespread research on
the use of periosteum-derived cells (PDPCs) for regenerative
approaches. Preclinical studies showing the potential of PDPCs
in the treatment of non-healing bone fractures and large bone
defects are currently available (Ferretti and Mattioli-Belmonte,
2014a). Upon bone injury, PDPCs tend to initiate endochondral
bone formation. This feature seems to be a unique periosteal
characteristic, as endosteal or bone marrow lesions heal by
intramembranous ossification (Colnot, 2009). This dissimilarity
in preferred bone formation is maintained even when cells have
been expanded ex vivo (van Gastel et al., 2014). Indeed, during
post-natal bone repair periosteum is the tissue mainly involved in
the generation of tissue-forming progenitors. However, multiple
adult stem cell populations can be induced into the osteogenic
and/or chondrogenic lineages in vitro, and as a consequence used
for skeletal regeneration.
Periodontal ligament (PDL) contains cell populations that can
differentiate into either cementum-forming cells (cementoblasts)
or bone-forming cells (osteoblasts) (Huang et al., 2009). This
suggests that PDL contains progenitor cells that maintain
periodontal tissue homeostasis and regeneration (Huang et al.,
2009). Indeed, PDL-SCs are able to form both soft and hard
periodontal tissues in vivo and are able to stimulate alveolar bone
formation (Seo et al., 2004).
At last, ASCs are easily achievable by lipoaspirates from
human adipose tissue (Kim and Heo, 2014). In current
literature, confident results of tissue engineering strategies for
the reconstruction of large osseous defects in orthopedic and
craniofacial surgery are available (Griffin et al., 2014; Marmotti
et al., 2014). At present, significant efforts have been made for
their application in cartilage regeneration (Griffin et al., 2014;
Marmotti et al., 2014).
For these reasons we decided to test PDPCs on both type of
scaffolds (with or without HA), using them to check PDL-SCs
osteogenic differentiation andASCs chondrogenic differentiation
capability, respectively.
Our results evidenced that PDL-SCs are less osteoblastic
committed in comparison with PDPCs and the latter seems to
be affected by scaffold structure/composition that accelerates cell
differentiation toward osteoblasts. This finding is in agreement
with our previous results in which we demonstrated the
importance of mechanical properties in the expression of PDPC
osteogenic genes and of HA in fastening this event (Mattei
et al., 2015). Studies comparing the osteogenic capacity of PDL-
SCs with other MSCs sources report conflicting data and this
contradiction may be at least in part explained by technical
differences between these researches, including cell passage
number and osteogenic conditions used. Therefore, as reported
by Liu et al. (2008) in an experimental animal model PDL-
SCs could be an ideal cellular source for periodontal ligament
regeneration and this PDL-SC mediated treatment could in turn
recover the heights of alveolar bone. As far as chondrogenic
differentiation is concerned, scaffold geometry seemed essential
to favor cells chondroblast differentiation, confirming recent
observation of other researchers (Chen et al., 2015; Dinescu et al.,
2015; Roberts et al., 2015).
In conclusion, the proposed 3D porous scaffolds differing in
chemical composition are confirmed as promising candidates
for osteochondral tissue regeneration applications. However,
in order to achieve a successful cell-based skeletal therapy of
different anatomical regions a correct stem cell source selection
is mandatory.
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